Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on IDA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115353511A details a safe Pd-catalyzed multicomponent route avoiding toxic CO gas, offering cost reduction in API manufacturing and scalable production.
Patent CN111423381A reveals a mild Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Novel iodine-promoted metal-free route for high-purity triazole intermediates. Reduces cost and simplifies supply chain for global pharma manufacturing.
Patent CN102746077B reveals a green iodine-catalyzed route for amide synthesis, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN101863954A details a high-yield 6-step route for N-tert-butyl-4-aza-5 alpha-androstane-3-ketone-17 beta-formamide, offering cost reduction in API manufacturing.
Novel Ag2O-promoted synthesis offers significant cost reduction and scalable production capabilities for high-purity pharmaceutical intermediates targeting global supply chains.
Novel metal-free oxidative cyclization method for high-purity triazole intermediates. Reduces cost and simplifies supply chain for pharma manufacturing.
Patent CN111423381B reveals a mild Pd-catalyzed route to 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN113735778B details efficient synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN111423381B reveals a mild palladium-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate supply.
Novel elemental sulfur-promoted method for 1,2,4-triazole intermediates. Eliminates explosive peroxides, ensures supply chain safety and cost reduction for pharma manufacturing.
Patent CN113307790B reveals a metal-free synthesis for 3-quinolyl-5-trifluoromethyl-1,2,4-triazoles, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN115353511A details a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN115353511A details a novel multi-component synthesis of carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN101735095A details a novel copper-catalyzed oxidative coupling for alpha-carbonyl amides, offering significant cost reduction and simplified supply chains for pharmaceutical intermediate manufacturing.
Patent CN111423381B reveals a mild palladium-catalyzed route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel radical cyclization method for benzimidazol[2,1-a]isoquinolin-6(5H)-ones. Efficient route reducing costs in pharmaceutical intermediate manufacturing with high purity.
Patent CN113683595B reveals sulfur-promoted synthesis eliminating heavy metals. Offers cost reduction in pharmaceutical intermediates manufacturing and scalable supply chain reliability.
Patent CN115353511A details a mild Pd-catalyzed route for biheterocycles, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel Pd-catalyzed carbonylation method for 2-CF3 imidazoles. High yield, mild conditions, scalable for reliable pharmaceutical intermediate supply chains.